| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2019/04/05 | 07 : 26 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/a) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 46 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 43 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 42 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 41 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 34 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 23 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 20 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 08 : 17 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 07 : 45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 07 : 45 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 06 : 44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/04 | 06 : 36 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/03 | 06 : 15 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/04/02 | 05 : 02 | Business Wire | Ironwood Pharmaceuticals Completes Separation of Cyclerion Therapeutics & Becomes a Gastrointestinal (GI)-focused Healthcare ... | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |
| 2019/03/30 | 05 : 42 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:CYCNV | CYCLERION THERAPEUTICS, INC. |